Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

PURPOSE: To study the prognostic value for overall survival of baseline assessment of functional status, comorbidity, and quality of life (QoL) in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy. PATIENTS AND METHODS: Data from 566 patients enrolled onto the phase III randomized Multicenter Italian Lung Cancer in the Elderly Study (MILES) study were analyzed. Functional status was measured as activities of daily living (ADL) and instrumental ADL (IADL). The presence of comorbidity was assessed with a checklist of 33 items; items 29 and 30 of the European Organisation for Research and Treatment of Cancer (EORTC) core questionnaire QLQ-C30 (EORTC QLQ-C30) were used to estimate QoL. ADL was dichotomized as none versus one or more dependency. For IADL and QoL, three categories were defined using first and third quartiles as cut points. Comorbidity was summarized using the Charlson scale. Analysis was performed by Cox model, and stratified by treatment arm. RESULTS: Better values of baseline QoL (P = .0003) and IADL (P = .04) were significantly associated with better prognosis, whereas ADL (P = .44) and Charlson score (P = .66) had no prognostic value. Performance status 2 (P = .006) and a higher number of metastatic sites (P = .02) also predicted shorter overall survival. CONCLUSIONS: Pretreatment global QoL and IADL scores, but not ADL and comorbidity, have significant prognostic value for survival of elderly patients with advanced non-small-cell lung cancer who were treated with chemotherapy. Using these scores in clinical practice might improve prognostic prediction for treatment planning.

In situ nondestructive identification of natural dyes in ancient textiles by reflection fourier transform mid-infrared (FT-MIR) spectroscopy.

Silk embroideries and cotton grounds of ancient Caucasian (Kaitag) textiles were analyzed in situ by a portable Fourier transform infrared (FT-IR) spectrometer equipped with a reflection module. Differently colored areas were analyzed for the purpose of identifying the dyes fixed on the fibers. The spectra so obtained were elaborated by calculating the corresponding second derivative, and a library search was then performed using a database including the second derivative spectra of a large range of historical dyes and the corresponding undyed fibers. The results presented here suggest that this technique, combined with the library search method, has a good capability of recognizing natural dyes on both types of ancient textile fibers, in an entirely non-destructive way.

Near-infrared reflectance models for the rapid prediction of quality of brewing raw materials.

Calibration models for quickly and reliably predicting moisture content and total nitrogen, both "as is" and "dry matter" on malt, as well as moisture content and total lipids, both "as is" and "dry matter", on maize by means of near-infrared (NIR) spectroscopy were developed. The FT-NIR spectra recorded on the finely ground cereals were correlated to the analytical data by means of the multivariate PLS algorithm. In particular, these models were developed on the raw materials, which are used by the main Italian brewing industries. Validation was carried out both by means of cross-validation and test set validation. Regression coefficients (R(2)) were higher than 97 for both malt and maize moisture content and higher than 85 and 88 for malt total nitrogen and maize total lipids, respectively. The RMSE values (both RMSECV and RMSEP) were lower than 0.1% m/m for both malt and maize moisture contents, whereas they ranged from 0.024 to 0.042% m/m for malt total nitrogen and from 0.042 to 0.055% m/m for maize total lipids. Repeatability was tested by taking into account more than one sample for each calibration and compared, when possible, to those of the standard methods. Repeatability (r(95)) ranged from 0.060 to 0.158% m/m and from 0.020 to 0.055% m/m for malt moisture and total nitrogen contents, respectively, and from 0.094 to 0.160% m/m and from 0.076 to 0.208% m/m for maize moisture and total lipids contents, respectively.

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.

PURPOSE: Paclitaxel/carboplatin (PC) is one of the reference combinations in the treatment of non-small-cell lung cancer (NSCLC). No triplet novel agent combination has until now shown superiority over a two-drug combination for advanced NSCLC. We therefore conducted a clinical trial to test if paclitaxel/carboplatin/gemcitabine (PCG) increases overall survival (OS) and response rate (RR) over PC. METHODS: Stage IIIB patients not suitable for radical radiation treatment and stage IV chemotherapy-naive patients with measurable disease and performance status of 0 to 2 were randomly assigned to PC arm (paclitaxel 200 mg/m2 and carboplatin area under the concentration-time curve 6 day 1/q21 days) or the PCG arm (paclitaxel 200 mg/m(2) and carboplatin area under the concentration-time curve 6 day 1, and gemcitabine 1,000 mg/m2 days 1 and 8 every 21 days). RESULTS: A total of 324 patients were randomly assigned to the two arms. The RR for PC arm and PCG arm were 20.2% and 43.6% [corrected] (P < .0001). The median time to the progression was 5.1 months in the PC group and 7.6 months in the PCG group (P = .012; hazard ratio [HR] 1.34; 95% CI: 1.06 to 1.72). Median OS was 8.3 months and 10.8 months (P = .032; HR 1.309; 95% CI: 1.03 to 1.67) in favor of the PCG arm. One-year survival was 34% (PC arm) and 45% (PCG arm; P = .032). Only hematologic toxicity (neutropenia, thrombocytopenia, and anemia) was significantly increased in the PCG arm and the experimental arm required more platelet and red blood cell transfusions, and more granulocyte colony-stimulating factor usage. No toxic/early deaths were observed. CONCLUSION: The PCG regimen offers a significant survival advantage over PC in advanced NSCLC, making PCG a treatment option for advanced NSCLC patients.